Comparison of foot pain and foot care among rheumatoid arthritis patients taking and not taking anti-TNFα therapy: An epidemiological study

Rheumatology International

Volumn 31, Issue 11, 2011, Pages 1515-1519

  Otter, S J ^a   Lucas, K ^a   Springett, K ^b   Moore, A ^a   Davies, K ^c   Young, A ^d   Walker Bone, K ^c  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b CANTERBURY CHRIST CHURCH UNIVERSITY   (United Kingdom)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^d Rheumatology Department   (United Kingdom)

Author keywords

Anti TNF ; Foot pain; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; B CELL INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CONTROLLED STUDY; FEMALE; FOOT; FOOT CARE; FOOT PAIN; HAND; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMEDICAL PROFESSION; PARESTHESIA; PODIATRY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RIGIDITY; SWELLING; UNITED KINGDOM; VISUAL ANALOG SCALE;

ARTHRITIS, RHEUMATOID; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FOOT; FOOT DISEASES; HUMANS; MALE; MIDDLE AGED; PAIN; PREVALENCE; QUESTIONNAIRES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83555163903     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1700-2     Document Type: Article

References (19)

1. JMC Albers L Paimela P Kurki, et al. 2001 Treatment strategy, disease activity and outcome in four cohorts of patients with early rheumatoid arthritis Ann Rheum Dis 60 453 458 11302866 10.1136/ard.60.5.453 1:STN:280: DC%2BD3M3oslOqug%3D%3D (Pubitemid 32417416)
2. B Combe R Landewe C Lukas, et al. 2007 EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics Ann Rheum Dis 66 34 45 16396980 10.1136/ard.2005.044354 1:STN:280:DC%2BD28jjvFCmsw%3D%3D (Pubitemid 46044858)
3. K Trieb 2005 Management of the foot in rheumatoid arthritis J Bone Joint Surg Br 87-B 1171 1177 10.1302/0301-620X.87B9.16288 (Pubitemid 41387552)
4. SJ Otter K Lucas K Springett, et al. 2010 Foot pain in rheumatoid arthritis prevalence and risk factors & management: an epidemiological study Clin Rheumatol 2 255 271 10.1007/s10067-009-1312-y
5. Helliwell P, Woodburn J, Redmond A et al (2007) The foot and ankle in rheumatoid arthritis. Churchill Livingstone, Edinburgh, pp 59-60
6. RL Ailinger E Schweitzer 1993 Patients' explanations of rheumatoid arthritis West J Nurs Res 15 340 351 8317116 10.1177/019394599301500306 1:STN:280:DyaK3szgtl2msw%3D%3D
7. AM Wickman MS Pinzur R Kadnoff, et al. 2004 Health-related quality of life for patients with rheumatoid arthritis foot involvement Foot Ankle Int 25 19 26 14768960 (Pubitemid 38139245)
8. L Grondal B Tengstrand B Nordmark, et al. 2008 The foot: still the most important reason for walking incapacity in rheumatoid arthritis: distribution of symptomatic joints in 1,000 RA patients Acta Orthop 79 257 261 18484253 10.1080/17453670710015067 (Pubitemid 351878358)
9. HJ Davys J Woodburn SJ Bingham P Emery 2006 Onychocryptosis (Ingrowing toenail) in patients with rheumatoid arthritis on biologic therapy Rheumatology 45 Supp 1 i171
10. GA Matricali A Boonen J Verduyckt, et al. 2006 The presence of forefoot problems and the role of surgery in patients with rheumatoid arthritis Ann Rheum Dis 65 1254 1255 16905588 10.1136/ard.2005.050823 1:STN:280: DC%2BD28vnvFOisQ%3D%3D (Pubitemid 44277414)
11. M Lohkamp G Burrow T McCarron, et al. 2006 The prevalence and anatomical location of foot pain in early diagnosed patients with rheumatoid arthritis Br J Podiatr 9 115 119
12. CM Bann SE Fehnel DD Gagnon 2003 Development and validation of the Diabetic Foot Ulcer Scale-short form (DFS-SF) Pharmacoeconomics 21 1277 1290 14986739 10.2165/00019053-200321170-00004 (Pubitemid 37523756)
13. AP Garrow AC Papageorgiou AJ Silman, et al. 2000 Development and validation of a questionnaire to assess disabling foot pain Pain 85 107 113 10692609 10.1016/S0304-3959(99)00263-8 1:STN:280:DC%2BD3c7lvFSqtA%3D%3D (Pubitemid 30110750)
14. National Institute for Health and Clinical Excellence Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis (TA130) (2007). Available from www.nice.org.uk. Accessed 1.5.2010
15. ML Prevoo MA van t'Hof HH Kuper, et al. 1995 Modified disease activity scores that indicate twenty-eight-joint counts Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44 48 7818570 10.1002/art.1780380107 1:STN:280:DyaK2M7hvVeqtA%3D%3D
16. BF Leeb I Andel S Leder, et al. 2005 The patient's perspective and rheumatoid arthritis disease activity indexes Rheumatology (Oxford) 44 360 365 10.1093/rheumatology/keh484 1:STN:280:DC%2BD2M%2FpvFaltA%3D%3D (Pubitemid 40361294)
17. AC Redmond R Waxman PS Helliwell 2005 Provision of foot health services in rheumatology in the UK Rheumatology (Oxford) 45 571 576 10.1093/rheumatology/ kei205
18. J Firth C Hale P Helliwell, et al. 2008 The prevalence of foot ulceration in patients with rheumatoid arthritis Arthritis Care Res 59 200 205 10.1002/art.23335 (Pubitemid 351272955)
19. SJ Otter CJ Robinson H Berry 2005 Rheumatoid arthritis, foot infection & tumour necrosis factor alpha inhibition-a case history The Foot 15 117 119 10.1016/j.foot.2005.02.010 (Pubitemid 40704394)